Head-to-head comparison of Tc-99m-sestamibi SPECT/CT and C-11-L-methionin PET/CT in parathyroid scanning before operation for primary hyperparathyroidism

S Vestergaard, O Gerke, M Bay, AR Madsen… - Molecular Imaging and …, 2023 - Springer
Purpose The preferred nuclear medicine method for identification of hyperfunctioning
parathyroid glands in hyperparathyroidism (HPT) develops continuously in relation to the …

18F-fluorocholine PET/CT is more sensitive than 11C-methionine PET/CT for the localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism

C Mathey, C Keyzer, D Blocklet… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Preoperative molecular imaging is paramount to direct surgery in primary
hyperparathyroidism (pHPT). We investigated the diagnostic performance of 18F …

18F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study

L Lezaic, S Rep, MJ Sever, T Kocjan… - European journal of …, 2014 - Springer
Purpose Primary hyperparathyroidism is a common endocrine disorder which is diagnosed
biochemically and for which therapy is surgical. A prerequisite for minimally invasive …

18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual …

M Beheshti, L Hehenwarter, Z Paymani… - European journal of …, 2018 - Springer
Purpose In this prospective study we compared the accuracy of 18 F-fluorocholine PET/CT
with that of 99m Tc-MIBI or 99m Tc-tetrofosmin SPECT/CT in the preoperative detection of …

18F-fluorocholine PET/CT in primary hyperparathyroidism: superior diagnostic performance to conventional scintigraphic imaging for localization of hyperfunctioning …

A Cuderman, K Senica, S Rep, M Hocevar… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Primary hyperparathyroidism (PHPT) is a common endocrine disorder, definitive treatment
usually requiring surgical removal of the offending parathyroid glands. To perform focused …

Usefulness of PET/CT with carbon-11-labeled methionine in the diagnosis of tertiary hyperparathyroidism

M Kołodziej, M Saracyn, A Lubas, M Dziuk, AD Durma… - Nutrients, 2022 - mdpi.com
Introduction: Tertiary hyperparathyroidism (tHP) may develop in patients treated with
hemodialysis or peritoneal dialysis. Parathyroidectomy may result in a significant reduction …

Comparison of five parathyroid scintigraphic protocols

V Tunninen, P Varjo, J Schildt, A Ahonen… - … journal of molecular …, 2013 - Wiley Online Library
Objectives. We compared five parathyroid scintigraphy protocols in patients with primary
(pHPT) and secondary hyperparathyroidism (sHPT) and studied the interobserver …

11C-Methionine PET/CT in patients with primary hyperparathyroidism and inconclusive pre-operative imaging work-up: diagnostic accuracy and role of semi …

D Maccora, C Caldarella, ML Calcagni - Annals of Nuclear Medicine, 2021 - Springer
Abstract Objective 11 C-Methionine PET/CT (C-MET) is a promising method in detecting
abnormal parathyroid glands in patients with primary hyperparathyroidism (PHPT). The first …

Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism

I Martínez-Rodríguez, N Martínez-Amador… - Revista Española de …, 2014 - Elsevier
Aim To evaluate the usefulness of 11 C-methionine PET/CT (MET) in the localization of the
parathyroid adenomas and to compare the results with those obtained with the conventional …

A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia

N Hayakawa, Y Nakamoto, K Kurihara… - Nuclear medicine …, 2015 - journals.lww.com
Objective The purpose of this study was to compare the sensitivity of single-photon emission
computed tomography/computed tomography (SPECT/CT) using 99m Tc-sestamibi (MIBI) …